Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

被引：0
|
作者：
Megan E. McNally
Antonio Martinez
Hooman Khabiri
Gregory Guy
Anthony J. Michaels
James Hanje
Robert Kirkpatrick
Mark Bloomston
Carl R. Schmidt
机构：
[1] The Ohio State University Medical Center,Department of Surgery
[2] The Ohio State University College of Medicine,Department of Radiology
[3] The Ohio State University Medical Center,Department of Medicine, Division of Gastroenterology
[4] The Ohio State University Medical Center,undefined
来源：
Annals of Surgical Oncology | 2013年 / 20卷
关键词：
Tace; Portal Vein Thrombosis; Radiographic Response; Tace Procedure; Ioxaglate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：923 / 928
页数：5
相关论文
共 50 条
  • [41] A novel model for the outcome prediction of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma with or without impaired hepatic function
    Kim, H. Y.
    Choi, A. R.
    Lee, H. A.
    Kim, T. H.
    Yoo, K.
    Kim, M.
    Choi, S. Y.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S209 - S210
  • [42] Survival outcome of hepatocellular carcinoma patients who underwent transarterial chemoembolization
    Corneja, Anna Lyn
    Que, Ernesto
    Morabe, Ferdinand
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A51 - A52
  • [43] Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective cohort study
    Zhao He
    Tsauo Jiaywei
    Zhang Xiaowu
    Ma Huaiyuan
    Weng Ningna
    Yang Zhengqiang
    Li Xiao
    中华医学杂志英文版, 2022, 135 (17)
  • [44] Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective cohort study
    Zhao, He
    Tsauo, Jiaywei
    Zhang, Xiaowu
    Ma, Huaiyuan
    Weng, Ningna
    Yang, Zhengqiang
    Li, Xiao
    CHINESE MEDICAL JOURNAL, 2022, 135 (17) : 2043 - 2048
  • [45] IMPACTS OF PRE-SARCOPENIA IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
    Rattanasupa, Attapon
    Chang, Arunchai
    GASTROENTEROLOGY, 2023, 164 (06) : S1410 - S1410
  • [46] Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
    Park, Joong-Won
    Koh, Young Hwan
    Kim, Hyun Beom
    Kim, Hwi Young
    An, Sangbu
    Choi, Joon-Il
    Woo, Sang Myung
    Nam, Byung-Ho
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1336 - 1342
  • [47] Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Zhao, Chang
    Fan, Liwei
    Qi, Feng
    Ou, Shengqiu
    Yu, Lei
    Yi, Xiaoyu
    Ni, Bingqiang
    Zheng, Zhiyong
    Lu, Jianxun
    Zhang, Chengwen
    Cheng, Changsheng
    Lu, Xiong
    Cheng, Lin
    Hu, Tianlian
    Ma, Yilong
    ANTI-CANCER DRUGS, 2016, 27 (07) : 689 - 694
  • [48] Transarterial chemoembolization in patients with unresectable diffuse vs. focal hepatocellular carcinoma.
    Pan, SH
    Ramirez, C
    Hoffman, A
    Linda, S
    Rojter, S
    Lopez, RR
    HEPATOLOGY, 1999, 30 (04) : 683A - 683A
  • [49] Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma - Comment
    Talamonti, MS
    O'Connell, TX
    Vauthey, JN
    Lopez
    ARCHIVES OF SURGERY, 2002, 137 (06) : 657 - 658
  • [50] Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis
    Georgiades, CS
    Hong, K
    D'Angelo, M
    Geschwind, JFH
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (12) : 1653 - 1659
12345